Author:
Weber Constance,Herwig-Carl Martina C.,Holz Frank G.,Mercieca Karl
Funder
Universitätsklinikum Bonn
Publisher
Springer Science and Business Media LLC
Reference7 articles.
1. Ahmed T, Honjo M, Sakata R, Fujishiro T, Shirato S, Aihara M (2022) Long-term results of the safety and effectiveness of a novel microshunt in Japanese patients with primary open-angle glaucoma. Jpn J Ophthalmol 66:33–40
2. Batlle JF, Corona A, Albuquerque R (2021) Long-term Results of the PRESERFLO MicroShunt in Patients With Primary Open-angle Glaucoma From a Single-center Nonrandomized Study. J Glaucoma 30:281–286
3. Beckers HJM, Aptel F, Webers CAB, Bluwol E, Martínez-de-la-Casa JM, García-Feijoó J, Lachkar Y, Méndez-Hernández CD, Riss I, Shao H, Pinchuk L, Angeles R, Sadruddin O, Shaarawy TM (2022) Safety and Effectiveness of the PRESERFLO® MicroShunt in Primary Open-Angle Glaucoma: Results from a 2-Year Multicenter Study. Ophthalmol Glaucoma 5:195–209
4. Bhayani R, Martínez de la Casa JM, Figus M, Klabe K, Rabiolo A, Mercieca K (2022) Short-term safety and efficacy of Preserflo™ Microshunt in glaucoma patients: a multicentre retrospective cohort study. Eye (Lond): 1–6
5. Gizzi C, Costa G, Servadei R, Abed E, Ning B, Sharma A, Barton K (2022) A case of malignant glaucoma following insertion of Preserflo™ MicroShunt. Eur J Ophthalmol 32(Np115):np119